Utilization of Pre-Exposure Prophylaxis among Adolescent Girls and Young Women Between 15 To 24 Yearsin Kisumu Municipalities, Kisumu County, Kenya
Article Details
Background: Clinical efficacy of the use of antiretroviral drugs (ARVs) by HIV-negative individuals to prevent sexual transmission of HIV has been extensively reported. Global estimates indicate that adolescent girls and young women accounts for 68% of the new HIV acquisitions among young people. Oral Pre -exposure prophylaxis (PrEP) use in adolescent girls and young women remains suboptimal in Kenya despite Pre-Exposure Prophylaxis being scaled up nationally. Objective: To establish determinants for utilization of pre-exposure prophylaxis among adolescent girls and young women between 15 to 24 years of age in KisumuMunicipality, Kisumu County. Design:A cross sectional study. Setting: Kajulu and Manyatta wards in Kisumu Municipality, Kisumu County, Kenya Subjects/Participants: Four Hundred and twenty two (422) participants drawn from a target population of 4000. The study used systematic sampling method. Semi-structured questionnaires were used to collect quantitative and qualitative data. Results: There was statistically significant association between girls and young women aged 15-24 years preferring PrEP and utilization of pre-exposure prophylaxis at a 5% level of significance (p-value = 0.000<0.05, X2 =50.892a, df 4), an association between PrEP services being offered for free or at a cost and utilization of pre-exposure prophylaxis at a 5% level of significance (p-value = 0.000<0.05, 2 =89.799a, df 2) , an association between nearest facility where girls and young women aged 15-24 years can access PrEP and utilization of PrEP at 5% level of significance (p-value = 0.000<0.05, 2 =30.465 a, df 3), association between quality of PrEP services in health facilities and utilization of PrEP was found to be statistically significant at a 5% level of significance (p value=0.011<0.05, 2 =,13.111adf 4), an association between recommendation/strategies given by respondents to improve uptake of PrEP and utilization of PrEP was statistically significant at 5% level of significance (p-value = 0.000<0.05, 2 =,70.476adf 4), an association between community talking about PrEP and utilization of PrEP was found to be statistically significant at a 5% level of significance (p-value = 0.004<0.05, 2 =8.515a, df 1), how the community portray the use of PrEP and utilization of PrEP was statistically significant at a 5% level of significance (p-value = 0.048<0.05, 2 =7.884aa, df 3) , association between social pressures within the community and utilization of PrEP was found to be statistically significant at a 5% level of significance (p value=0.001<0.05, 2 =,13.690adf 4) Conclusion: Socio-economic, Socio-Behavioural, Structural and Socio Culture played a greater role in determining utilization of pre-exposure prophylaxis among adolescent girls and young women between the ages of 15 to 24 years in Kisumu municipality, Kisumu County.
_report_en.pdf, accessed 4 July 2019).
2. UNAIDS. 2016. “HIV Prevention among Adolescent Girls and Young Women.”
3. Young, Ingrid, Paul Flowers, and Lisa M. McDaid. 2014. “Barriers to Uptake and Use of Pre-Exposure Prophylaxis (PrEP) among Communities Most Affected by HIV in the UK: Findings from a Qualitative Study in Scotland.” BMJ Open 4(11): 1–8.
4. Arnold, Trisha et al. 2017. “Social, Structural, Behavioral and Clinical Factors Influencing Retention in Pre-Exposure Prophylaxis (PrEP) Care in Mississippi.” PLoS ONE 12(2): 1–10.
5. Ministry of Health, Kenya National AIDS report 2018
6. Ministry of Health, Kenya AIDS Indicators survey 2012-2013
7. Dellar, R, Dlamini. S, Karim. Q, Adolescent girls and young women: key populations for HIV epidemic control, Published 1 February 2015Medicine, Journal of the International AIDS Society
8. UNAIDS, Joint united Nation programme on HIV, 2015
9. PEPFAR Annual report to Congress 2015
10. Investing to End Epidemics: The Global Fund Strategy 2017-2022
11. LoVette A, Kuo C, Giovenco D, Hoare J, Underhill K, Operario D. Pre-exposure prophylaxis as an opportunity for engagement in HIV prevention among South African adolescents. SAHARA J. 2022 Dec; 19(1):1-7. doi: 10.1080/17290376.2021.2016479. PMID: 35135437; PMCID:PMC88432
04.
12. Gray, Megan E, Sheela V Shenoi, and Rebecca Dillingham. 2018. “Pre-Exposure Prophylaxis as HIV Prevention in High-Risk Adolescents.” 2(1): 5–10.
13. Mayer, K.H., Agwu, A. & Malebranche, D. Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review. Adv Ther 37, 1778–1811 (2020). https://doi.org/10.1007/s12325-020-01295-0
14. ATHENA. 2017. “A Review of the Pre-Exposure Prophylaxis (PrEP) Research and Evidence Landscape in Kenya and Uganda for Adolescent Girls and Young Women.” (July).
15. Lim, Sin How et al. 2017. “Willingness to Use Pre-Exposure Prophylaxis for HIV Prevention among Men Who Have Sex with Men in Malaysia: Findings from an Online Survey.” PLoS ONE 12(9): 1–19.
16. Draft, Final, and Final Draft. 2016. “Guidelines for Expanding Combination Prevention and Treatment Options for Sex Workers : Oral Pre-Exposure Prophylaxis (PrEP) and Test and Treat (T & T).” (May).